Related Experiment Video
Updated: Aug 11, 2026
05:53
Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Inflammation markers predicting frailty and mortality in the elderly
Massimo De Martinis1, Claudio Franceschi, Daniela Monti
1Department of Internal Medicine, University of L'Aquila, Via S.Sisto, 22/E, 67100 L'Aquila, Italy.
Experimental and Molecular Pathology
|February 8, 2006
Summary
As people live longer, identifying functional decline is key. Inflammation markers are powerful predictors of frailty and mortality in the elderly, aiding targeted therapies.
Area of Science:
- Gerontology and aging research.
- Biomarker discovery for healthspan.
- Clinical geriatrics and public health.
Background:
- Increasing global longevity presents challenges in maintaining functional independence.
- Identifying physiological markers for functional decline and mortality risk is crucial for targeted interventions.
- Senescence is understood as a result of lifelong antigenic stress interacting with genetic predispositions.
Purpose of the Study:
- To review current research on aging and translate findings into practical clinical tools.
- To explore the utility of inflammation markers as predictors of adverse outcomes in older adults.
- To suggest novel approaches for the clinical management of aging populations.
Main Methods:
- Review of existing research on aging, senescence, and biomarkers.
- Analysis of inflammation markers as indicators of lifelong attrition and genetic susceptibility.
- Synthesis of evidence linking biomarkers to frailty and mortality in the elderly.
Main Results:
- Inflammation markers serve as synthetic measures of cumulative physiological stress and genetic factors.
- These biomarkers are currently the strongest predictors of frailty and mortality in older individuals.
- The findings support the potential for using inflammation markers in clinical risk assessment.
Conclusions:
- Inflammation markers offer a promising avenue for identifying elderly individuals at risk of functional decline.
- Translating aging research into clinical practice can lead to improved health outcomes for older adults.
- Targeted therapies based on these biomarkers could mitigate adverse events and enhance quality of life in advanced age.
Related Concept Videos
01:30Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:38Inflammation
Overview